Sign Out
Hypersensitivity to active substance, to GnRH, its analogues or to any of the excipients (see Adverse Reactions).
Pregnancy and breast feeding.
3.75 mg: In the pre-menopausal breast cancer setting: Initiation of aromatase inhibitor treatment before adequate ovarian suppression with triptorelin has been achieved (see Dosage & Administration and Precautions).
